Switching molecules and switchable chimeric antigen receptors
US2021061907A1
Antibody or antigen-binding fragment thereof that specifically recognizes b cell malignancies, chimeric antigen receptor comprising same, and uses thereof
AU2018379502A1
Antibody or antigen binding fragment thereof for specifically recognizing B cell malignancy, chimeric antigen receptor comprising same, and use thereof
KR20180081029A
Antibodies Capable of Binding Specifically to CD80 and CD86
KR20180117242A
A Polypeptide Having Improved Purity Of Protein And Affinity For Antigen, A Complex With An Antibody Or Antigen-binding Fragment Thereof, And A Method For Producing The Same
KR20170117330A
Antibodies Binding Specifically to HER2 with Improved Stability
KR20180025335A
Myeloma Cell Over-expressing XIAP Protein
KR20160022857A
Antibodies Capable of Binding Specifically to HER2
KR20170071680A
Antibodies Capable of Binding Specifically to CD80 and CD86
KR20170064086A
Antibodies Capable of Binding Specifically to VEGFR2
KR20170012754A
Antibodies Capable of Binding Specifically to EGFR
KR20160083493A
Antibody Libraries and Methods for Preparation of Them
KR20150130893A
Antibodies Capable of Binding Specifically to HER2
KR101453462B1
Antibodies Capable of Binding Specifically to HER2
